Table 3.
Analyte | Positive samples > LOD (%) | Positives samples > LLOQ (%) | Mean concentration in diluted urine samples (0.5 mg/mL creatinine) (ng/mL) ± SD | Median concentration in diluted urine samples (0.5 mg/mL creatinine) (ng/mL) |
Range (ng/mL) | Mean concentration (ng/mg creatinine) ± SD | Median concentration (ng/mg creatinine) | Range (ng/mg creatinine) |
---|---|---|---|---|---|---|---|---|
DON | 46 | 26 | 7.02 ± 7.36 | 1.64 | 2–20 | 0.24 ± 0.11 | 0.23 | 0.12–0.31 |
ZEN | 75 | 53 | 0.36 ± 0.31 | 0.27 | 0.1–1.5 | 0.16 ± 0.13 | 0.15 | 0.02–0.30 |
α-ZEL | 46 | 4 | 0.54 ± 0.01 | 0.54 | 0.4–0.5 | 0.18 ± 0.01 | 0.18 | 0.17–0.19 |
β-ZEL | 9 | 0 | - | - | - | - | - | - |
OTA | 56 | 26 | 3.55 ± 3.41 | 2.48 | 1.5–15 | 1.74 ± 2.34 | 0.90 | 0.15–9.81 |
AOH | 54 | 11 | 2.35 ± 1.54 | 1.97 | 1–4.4 | 0.99 ± 0.57 | 0.95 | 0.22–1.89 |
AME | 73 | 16 | 0.37 ± 0.25 | 0.24 | 0.2–0.3 | 0.09 ± 0.03 | 0.10 | 0.05–0.12 |